GlassScriptPhysician profile
Nelson Juarez
NPI 1215958996
$1,387.08
in general payments reported to CMS, 2019-2025
7 companies · $738 in 2025
The $738 reported for 2025 was more than what 86% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $312 · 2020: $37.69 · 2021: $77.96 · 2022: $126 · 2023: $51.32 · 2024: $43.79 · 2025: $738.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $833.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $833.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $663.62 | 2019-2025 | Precision7 |
| Johnson & Johnson Vision Care, INC. | $369.76 | 2022-2025 | Acuvue |
| Coopervision INC. | $118.25 | 2025 | Clariti Contact Lens |
| Glaukos Corporation | $81.42 | 2025 | Photrexa Viscous and Photrexa, Kxl System (Not Refurbished) |
| Bausch & Lomb Americas INC. | $65.77 | 2025 | Infuse |
| Abbvie INC. | $51.53 | 2022 | |
| Abb Con-Cise Optical Group LLC | $36.73 | 2021-2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nelson Juarez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.